Samsung Electronics has announced a new partnership with Alcedis, a digital-first clinical research organization (CRO), aimed at transforming health data collected from wearable devices into meaningful evidence for clinical trials.
The collaboration is designed to help pharmaceutical companies and research organizations improve the efficiency of clinical studies while reducing costs and development time.
Wearable devices have become an increasingly popular tool for collecting continuous health data in real-world settings. However, researchers often face challenges when trying to convert the vast amount of wearable-generated information into clinically relevant insights. Samsung and Alcedis aim to address this problem by combining advanced wearable technology with clinical research expertise.
The partnership will leverage Samsung’s Galaxy Watch platform, which can continuously collect physiological data from users who provide consent. Samsung’s approach includes clinically validated measurements such as bioelectrical impedance analysis (BIA) and electrodermal activity (EDA), along with Software as a Medical Device (SaMD) features, including obstructive sleep apnea and atrial fibrillation detection.
Samsung said its research platform enables researchers to access detailed biosensor data and participant insights while maintaining study-specific controls and protocols. The company believes this will support the development of digital biomarkers and clinical endpoints, helping researchers generate stronger evidence from real-world health data.
According to Samsung, the collaboration reflects a growing trend toward connected and data-driven healthcare research. By combining wearable technology, scientific expertise, and research infrastructure, the companies hope to accelerate biomarker development, improve clinical trial design, and support more patient-focused healthcare innovations.
If this article helped you, please consider supporting our work. Every small contribution keeps Abijita.com independent and running.
Under the agreement, Alcedis will oversee study execution and participant engagement, while Samsung will provide wearable devices and research infrastructure. The companies say the partnership could help bridge the gap between everyday health monitoring and scientific research, enabling faster evidence generation and deeper insights into human health.
Samsung Partners With Alcedis to Bring Galaxy Watch Data Into Clinical Research
